Pharmaceutical Product Monograph: Calcium Dobesilate (500 mg)
In the pharmaceutical industry, Calcium Dobesilate is a potent Vasoactive and Venotonic agent. As a pharmacist and manufacturer, I view this molecule as a “Microvascular Stabilizer”—it is technically designed to act on the capillary walls to reduce permeability and improve blood flow.
At your WHO-GMP facility in Mumbai, this is a high-value SKU for Ophthalmology, Dermatology, and Vascular Surgery portfolios. It is particularly effective for chronic conditions where “leaky” or fragile blood vessels are the primary concern.
Therapeutic Profile: Primary Indications
Calcium Dobesilate is primarily used to treat microcirculatory disorders.
| Indication | Clinical Context | Technical Rationale |
| Diabetic Retinopathy | Ophthalmology | Reduces capillary fragility and hemorrhages in the retina of diabetic patients. |
| Chronic Venous Insufficiency (CVI) | Vascular Health | Relieves leg pain, heaviness, and swelling (edema) caused by poor vein function. |
| Hemorrhoids | Proctology | Reduces inflammation and bleeding in the rectal area by stabilizing local micro-vessels. |
| Diabetic Microangiopathy | Endocrinology | Protects small blood vessels throughout the body from damage caused by high blood sugar. |
Mechanism: Capillary Stabilization & Hemorheology
Calcium Dobesilate works through a multi-modal technical pathway:
Endothelial Protection: It increases the activity of nitric oxide synthase in the vessel walls, which helps the blood vessels relax and stay healthy.
Permeability Reduction: It technically inhibits inflammatory substances like histamine and bradykinin, which normally cause vessels to “leak” fluid into surrounding tissue (edema).
Platelet Inhibition: It slightly reduces platelet aggregation and lowers blood viscosity (thickness), which improves the flow of blood through tiny capillaries.
Lymphatic Drainage: It stimulates the lymphatic system to remove excess fluid from tissues more efficiently.
The Pharmacist’s “Technical Warning”
The “Renal” Rule: Calcium Dobesilate is primarily excreted by the kidneys. In patients with severe Renal Failure (dialysis), the dose must be reduced or the drug avoided.
Gastrointestinal Distress: Some patients may experience nausea or diarrhea. Taking the capsule with meals can technically improve tolerance.
Agranulocytosis: Though very rare, this drug can cause a sudden drop in white blood cells. If a patient develops a high fever or severe sore throat, they must stop the drug and get a blood test immediately.
Fever Reaction: If a patient develops a “drug fever,” it is a technical sign of hypersensitivity, and the medication should be discontinued.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at Healthy Life Pharma / Healthy Inc:
The “Niche Market” USP: On your digital marketplace, highlight Calcium Dobesilate as a “Specialized Microvascular Solution.” This attracts high-value inquiries from Diabetology and Eye Care clinics.
Stability in Export: Calcium Dobesilate is relatively stable, but for B2B export to “Zone IVb” regions, ensure your Alu-Alu or PVC/PVDC blistering is validated to prevent any oxidative degradation of the active ingredient.
The “Synergy” Portfolio: Market this alongside your Metformin or Vildagliptin range. This creates a “Complete Diabetic Care” package for international tenders.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your registration in international B2B markets.